Literature DB >> 15067092

B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.

Pablo A Silveira1, Joseph Dombrowsky, Ellis Johnson, Harold D Chapman, David Nemazee, David V Serreze.   

Abstract

One mechanism whereby B cells contribute to type 1 diabetes in nonobese diabetic (NOD) mice is as a subset of APCs that preferentially presents MHC class II-bound pancreatic beta cell Ags to autoreactive CD4 T cells. This results from their ability to use cell surface Ig to specifically capture beta cell Ags. Hence, we postulated a diabetogenic role for defects in the tolerance mechanisms normally blocking the maturation and/or activation of B cells expressing autoreactive Ig receptors. We compared B cell tolerance mechanisms in NOD mice with nonautoimmune strains by using the IgHEL and Ig3-83 transgenic systems, in which the majority of B cells recognize one defined Ag. NOD- and nonautoimmune-prone mice did not differ in ability to delete or receptor edit B cells recognizing membrane-bound self Ags. However, in contrast to the nonautoimmune-prone background, B cells recognizing soluble self Ags in NOD mice did not undergo partial deletion and were also not efficiently anergized. The defective induction of B cell tolerance to soluble autoantigens is most likely responsible for the generation of diabetogenic APC in NOD mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067092      PMCID: PMC3792717          DOI: 10.4049/jimmunol.172.8.5086

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

Review 2.  Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice.

Authors:  D V Serreze; E H Leiter
Journal:  Curr Dir Autoimmun       Date:  2001

3.  Development of type 1 diabetes despite severe hereditary B-cell deficiency.

Authors:  S Martin; D Wolf-Eichbaum; G Duinkerken; W A Scherbaum; H Kolb; J G Noordzij; B O Roep
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

4.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21.

Authors:  A Cariappa; M Tang; C Parng; E Nebelitskiy; M Carroll; K Georgopoulos; S Pillai
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

5.  Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice.

Authors:  H T Kreuwel; J A Biggs; I M Pilip; E G Pamer; D Lo; L A Sherman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

6.  A defect in central tolerance in NOD mice.

Authors:  H Kishimoto; J Sprent
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

7.  B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice.

Authors:  C Hulbert; B Riseili; M Rojas; J W Thomas
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

8.  Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development.

Authors:  Thomas T Su; David J Rawlings
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

9.  Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.

Authors:  H Noorchashm; D J Moore; L E Noto; N Noorchashm; A J Reed; A L Reed; H K Song; R Mozaffari; A M Jevnikar; C F Barker; A Naji
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

10.  Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice.

Authors:  P P Chiu; D V Serreze; J S Danska
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

View more
  28 in total

1.  Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.

Authors:  Peggy L Kendall; Daniel J Moore; Chrys Hulbert; Kristen L Hoek; Wasif N Khan; James W Thomas
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

2.  Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.

Authors:  James B Case; Rachel H Bonami; Lindsay E Nyhoff; Hannah E Steinberg; Allison M Sullivan; Peggy L Kendall
Journal:  J Immunol       Date:  2015-06-01       Impact factor: 5.422

3.  Subcongenic analyses reveal complex interactions between distal chromosome 4 genes controlling diabetogenic B cells and CD4 T cells in nonobese diabetic mice.

Authors:  Jessica Stolp; Yi-Guang Chen; Selwyn L Cox; Vivien Henck; Wenyu Zhang; Shirng-Wern Tsaih; Harold Chapman; Timothy Stearns; David V Serreze; Pablo A Silveira
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

4.  Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.

Authors:  Rachel H Bonami; James W Thomas
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

Review 5.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 6.  Role of B lymphocytes in the pathogenesis of type 1 diabetes.

Authors:  Rochelle M Hinman; John C Cambier
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 7.  Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.

Authors:  Shabbir Hussain; Melany Wagner; Dalam Ly; Terry L Delovitch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  B cells regulate CD4+ T cell responses to papain following B cell receptor-independent papain uptake.

Authors:  Daniel F Dwyer; Matthew C Woodruff; Michael C Carroll; K Frank Austen; Michael F Gurish
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

Review 9.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

10.  B cells in autoimmune diabetes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2005-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.